http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190029355-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_143ac4fbe1e063c6a828a96cfffc34d5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166 |
| filingDate | 2017-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8fe03dbddafa4ce69a225fe0e8bc095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cc0122a37366b178c02c2a576f8b981 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b231376d0a664327cc117fbdc854ca72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e4e420b3d23f0b1956414e1ef03217c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffd384a89b6dc1544e17d51f6b38f6c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b31ce22f1714a892c27dceed24894f6e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d665204b2213ed95469ba1b8329c6152 |
| publicationDate | 2019-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20190029355-A |
| titleOfInvention | Once a day oral dosage sustained-release formulation comprising itopride |
| abstract | The sustained-release sustained-release double-layered tablets containing the itopride hydrochloride of the present invention can be used as an immediate release layer for rapidly eluting the drug and a slow release layer for gradual release in order to simultaneously satisfy rapid pharmacological activity development and sustained pharmacological activity for 24 hours Hydroxypropylmethylcellulose having a specific degree of substitution and viscosity according to a specific degree of substitution and viscosity is used as a release controlling agent and a dissolution rate in each portion of the gastrointestinal tract having different pH And the residence time in the gastrointestinal tract. The present invention also provides a method for preparing an itopride hydrochloride-containing sustained-release sustained-release biodegradable tablet, which is designed to prevent adverse effects due to excessive release of the initial effective ingredient while maintaining compliance with the patient's medication and maintain a uniform dissolution rate. |
| priorityDate | 2017-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.